2023
DOI: 10.1139/bcb-2022-0331
|View full text |Cite
|
Sign up to set email alerts
|

The nuclear receptor subfamily 4 group A1 in human disease

Abstract: Nuclear receptor 4A1 (NR4A1), a member of the NR4A subfamily, acts as a gene regulator in a wide range of signaling pathways and responses to human diseases. Here, we provide a brief overview of the current functions of NR4A1 in human diseases and the factors involved in its function. A deeper understanding of these mechanisms can potentially improve drug development and disease therapy.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(4 citation statements)
references
References 143 publications
0
2
0
Order By: Relevance
“…The BMP family has also been well-described to exhibit anti-fibrotic effects (De Langhe et al, 2015;Guan et al, 2022;Pegorier et al, 2010;Tan et al, 2019). The anti-fibrotic effects of the nuclear receptor family and aldehyde dehydrogenase (ALDH) gene superfamily have been shown in our previous work (Tan et al, 2021) and by others (Ma et al, 2018;Takahashi et al, 2021;Wang et al, 2023). Pentraxin 3 (Ptx3) has been shown to protect against BLM-induced lung fibrosis in mice as well (Maccarinelli et al, 2021).…”
Section: Discussionmentioning
confidence: 86%
See 1 more Smart Citation
“…The BMP family has also been well-described to exhibit anti-fibrotic effects (De Langhe et al, 2015;Guan et al, 2022;Pegorier et al, 2010;Tan et al, 2019). The anti-fibrotic effects of the nuclear receptor family and aldehyde dehydrogenase (ALDH) gene superfamily have been shown in our previous work (Tan et al, 2021) and by others (Ma et al, 2018;Takahashi et al, 2021;Wang et al, 2023). Pentraxin 3 (Ptx3) has been shown to protect against BLM-induced lung fibrosis in mice as well (Maccarinelli et al, 2021).…”
Section: Discussionmentioning
confidence: 86%
“…Five hundred and ten of 595 genes (85.7%) that significantly increase during both processes increase more following BLM, whereas 200 of 267 (74.9%) common decreased genes decrease more following BLM. Furthermore, we identified several genes previously documented to moderate pro‐fibrotic responses uniquely upregulated after PNX but not BLM (Figure 3f), including Ptgs2 , responsible for synthesis of the antifibrotic prostaglandin E2 (Bauman et al., 2010; Huang et al., 2007; Keerthisingam et al., 2001; Lama et al., 2002), Bone Morphogenetic Protein (BMP) ligands ( Bmp2 , Bmp7 ) (De Langhe et al., 2015; Guan et al., 2022; Pegorier et al., 2010; Tan et al., 2019), the Nuclear Receptor 4A (NR4A) Family ( Nr4a1 , Nr4a2 , Nr4a3 ), and the aldehyde dehydrogenase (ALDH) gene superfamily ( Aldh1a1 ) (Ma et al., 2018; Takahashi et al., 2021; Wang et al., 2023). These previously described anti‐fibrotic transcripts elevated after PNX but not BLM might contribute to the lower magnitude of fibrotic responses in PNX compared with BLM (Figure 3e).…”
Section: Resultsmentioning
confidence: 99%
“…Nr4a1 is an activity‐dependent transcription factor rapidly transcribed in response to neuronal activity and stress 46 . Nr4a1 , a key mediator during the regulation of inflammatory disease factors, 47 could inactivate the MAPK/ERK/CREB signaling pathway 48 . Up‐regulation of Nr4a1 expression may inhibit oxidative stress induced volatile antidepressant effects 49 .…”
Section: Discussionmentioning
confidence: 99%
“… 46 Nr4a1 , a key mediator during the regulation of inflammatory disease factors, 47 could inactivate the MAPK/ERK/CREB signaling pathway. 48 Up‐regulation of Nr4a1 expression may inhibit oxidative stress induced volatile antidepressant effects. 49 According to clinical studies, the expression level of inflammatory factor Nr4a1 was significantly downregulated in the transcriptome sequencing of the dentate gyrus in the MDD patients compared with the control, suggesting that neuroinflammation plays a crucial role in MDD.…”
Section: Discussionmentioning
confidence: 99%